RC48-ADC Tackles Advanced Urothelial Cancer Effectively
In a groundbreaking advancement for urothelial carcinoma (UC) treatment, recent findings have shed light on the therapeutic potential of RC48-ADC, an antibody-drug conjugate targeting HER2-low...